Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.49059518 |
2 | L-phenylalanine catabolic process (GO:0006559) | 5.49059518 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.96940808 |
4 | L-phenylalanine metabolic process (GO:0006558) | 4.96940808 |
5 | fatty acid elongation (GO:0030497) | 4.54587466 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 4.34831610 |
7 | response to methylmercury (GO:0051597) | 4.30776104 |
8 | axon ensheathment in central nervous system (GO:0032291) | 4.27881777 |
9 | central nervous system myelination (GO:0022010) | 4.27881777 |
10 | gas transport (GO:0015669) | 4.17981863 |
11 | oxygen transport (GO:0015671) | 4.17005882 |
12 | cysteine metabolic process (GO:0006534) | 4.05086231 |
13 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.91238699 |
14 | Golgi transport vesicle coating (GO:0048200) | 3.73365437 |
15 | COPI coating of Golgi vesicle (GO:0048205) | 3.73365437 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72304923 |
17 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.69113595 |
18 | glyoxylate metabolic process (GO:0046487) | 3.63387615 |
19 | bile acid biosynthetic process (GO:0006699) | 3.60790186 |
20 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.49384943 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.48534054 |
22 | heme transport (GO:0015886) | 3.45906625 |
23 | short-chain fatty acid metabolic process (GO:0046459) | 3.43566020 |
24 | acetyl-CoA metabolic process (GO:0006084) | 3.39351590 |
25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.38383890 |
26 | indole-containing compound catabolic process (GO:0042436) | 3.32441962 |
27 | indolalkylamine catabolic process (GO:0046218) | 3.32441962 |
28 | tryptophan catabolic process (GO:0006569) | 3.32441962 |
29 | creatine metabolic process (GO:0006600) | 3.29705343 |
30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.27650339 |
31 | very long-chain fatty acid metabolic process (GO:0000038) | 3.27270527 |
32 | drug transmembrane transport (GO:0006855) | 3.25677010 |
33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.25150262 |
34 | glutamate metabolic process (GO:0006536) | 3.24862884 |
35 | cerebellar granule cell differentiation (GO:0021707) | 3.24664396 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 3.23688460 |
37 | plasma lipoprotein particle clearance (GO:0034381) | 3.22791579 |
38 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.22718615 |
39 | sulfur amino acid catabolic process (GO:0000098) | 3.21554310 |
40 | kynurenine metabolic process (GO:0070189) | 3.20613775 |
41 | lysine metabolic process (GO:0006553) | 3.19135997 |
42 | lysine catabolic process (GO:0006554) | 3.19135997 |
43 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.18615445 |
44 | hemoglobin metabolic process (GO:0020027) | 3.18024989 |
45 | aspartate family amino acid catabolic process (GO:0009068) | 3.17199871 |
46 | acyl-CoA biosynthetic process (GO:0071616) | 3.16652689 |
47 | thioester biosynthetic process (GO:0035384) | 3.16652689 |
48 | coenzyme catabolic process (GO:0009109) | 3.15859815 |
49 | tryptophan metabolic process (GO:0006568) | 3.13856982 |
50 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.13063796 |
51 | bile acid metabolic process (GO:0008206) | 3.11644571 |
52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.11623370 |
53 | protein carboxylation (GO:0018214) | 3.11623370 |
54 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.06883920 |
55 | negative regulation of fibrinolysis (GO:0051918) | 3.05865741 |
56 | amino-acid betaine metabolic process (GO:0006577) | 3.01737217 |
57 | tyrosine metabolic process (GO:0006570) | 3.01206453 |
58 | regulation of ARF protein signal transduction (GO:0032012) | 2.97294289 |
59 | aromatic amino acid family metabolic process (GO:0009072) | 2.97281459 |
60 | acylglycerol homeostasis (GO:0055090) | 2.96779674 |
61 | triglyceride homeostasis (GO:0070328) | 2.96779674 |
62 | high-density lipoprotein particle remodeling (GO:0034375) | 2.96487385 |
63 | positive regulation of receptor recycling (GO:0001921) | 2.96246994 |
64 | urea cycle (GO:0000050) | 2.95252343 |
65 | urea metabolic process (GO:0019627) | 2.95252343 |
66 | cellular ketone body metabolic process (GO:0046950) | 2.94922733 |
67 | regulation of fibrinolysis (GO:0051917) | 2.93776798 |
68 | synaptic vesicle maturation (GO:0016188) | 2.93619147 |
69 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.91608782 |
70 | regulation of cholesterol metabolic process (GO:0090181) | 2.90281027 |
71 | acyl-CoA metabolic process (GO:0006637) | 2.90220006 |
72 | thioester metabolic process (GO:0035383) | 2.90220006 |
73 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.89863197 |
74 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.89033796 |
75 | regulation of cholesterol homeostasis (GO:2000188) | 2.88112858 |
76 | complement activation, alternative pathway (GO:0006957) | 2.87189482 |
77 | alpha-amino acid catabolic process (GO:1901606) | 2.85105898 |
78 | iron coordination entity transport (GO:1901678) | 2.85100785 |
79 | fatty acid oxidation (GO:0019395) | 2.85082017 |
80 | negative regulation of digestive system process (GO:0060457) | 2.84553587 |
81 | cholesterol efflux (GO:0033344) | 2.83920793 |
82 | synaptic vesicle exocytosis (GO:0016079) | 2.83847300 |
83 | ensheathment of neurons (GO:0007272) | 2.83538240 |
84 | axon ensheathment (GO:0008366) | 2.83538240 |
85 | regulation of protein activation cascade (GO:2000257) | 2.82738341 |
86 | nitrogen cycle metabolic process (GO:0071941) | 2.82611818 |
87 | response to mercury ion (GO:0046689) | 2.82539638 |
88 | drug catabolic process (GO:0042737) | 2.82339324 |
89 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.81788379 |
90 | cofactor catabolic process (GO:0051187) | 2.81613146 |
91 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81135568 |
92 | fatty acid catabolic process (GO:0009062) | 2.81035292 |
93 | fatty acid beta-oxidation (GO:0006635) | 2.80240639 |
94 | lipid oxidation (GO:0034440) | 2.78521239 |
95 | ethanol oxidation (GO:0006069) | 2.78392020 |
96 | cholesterol biosynthetic process (GO:0006695) | 2.78219349 |
97 | plasma lipoprotein particle assembly (GO:0034377) | 2.77346353 |
98 | myelination (GO:0042552) | 2.76752865 |
99 | import into cell (GO:0098657) | 2.76617938 |
100 | cellular amino acid catabolic process (GO:0009063) | 2.75923560 |
101 | glycerophospholipid catabolic process (GO:0046475) | 2.75878386 |
102 | cell migration in hindbrain (GO:0021535) | 2.75097380 |
103 | regulation of bile acid biosynthetic process (GO:0070857) | 2.74121231 |
104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.73215833 |
105 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.73215833 |
106 | fibrinolysis (GO:0042730) | 2.72682218 |
107 | serine family amino acid catabolic process (GO:0009071) | 2.72367151 |
108 | protein-lipid complex assembly (GO:0065005) | 2.72316550 |
109 | glutamate secretion (GO:0014047) | 2.70496286 |
110 | myelin maintenance (GO:0043217) | 2.69808220 |
111 | vesicle coating (GO:0006901) | 2.69526542 |
112 | monocarboxylic acid catabolic process (GO:0072329) | 2.69510274 |
113 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66898111 |
114 | regulation of response to osmotic stress (GO:0047484) | 2.66824533 |
115 | response to lead ion (GO:0010288) | 2.66799137 |
116 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.65564363 |
117 | glutathione biosynthetic process (GO:0006750) | 2.64748422 |
118 | cellular modified amino acid catabolic process (GO:0042219) | 2.64707642 |
119 | homocysteine metabolic process (GO:0050667) | 2.63586146 |
120 | negative regulation of lipase activity (GO:0060192) | 2.63382124 |
121 | protein localization to endosome (GO:0036010) | 2.62684594 |
122 | positive regulation of lipid catabolic process (GO:0050996) | 2.62544649 |
123 | regulation of complement activation (GO:0030449) | 2.62540016 |
124 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.61986400 |
125 | phospholipid efflux (GO:0033700) | 2.61936070 |
126 | reverse cholesterol transport (GO:0043691) | 2.60668667 |
127 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.59562187 |
128 | erythrocyte development (GO:0048821) | 2.59371979 |
129 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.55255663 |
130 | mannose metabolic process (GO:0006013) | 2.54057202 |
131 | stress fiber assembly (GO:0043149) | 2.50548788 |
132 | cellular response to catecholamine stimulus (GO:0071870) | 2.49692570 |
133 | cellular response to monoamine stimulus (GO:0071868) | 2.49692570 |
134 | neuronal ion channel clustering (GO:0045161) | 2.45096826 |
135 | protein targeting to plasma membrane (GO:0072661) | 2.43440807 |
136 | protein retention in ER lumen (GO:0006621) | 2.42196010 |
137 | regulation of synaptic vesicle transport (GO:1902803) | 2.42058366 |
138 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41568284 |
139 | L-serine transport (GO:0015825) | 2.35735932 |
140 | layer formation in cerebral cortex (GO:0021819) | 2.34700022 |
141 | activation of protein kinase A activity (GO:0034199) | 2.32118786 |
142 | negative regulation of microtubule polymerization (GO:0031115) | 2.29231599 |
143 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.29031533 |
144 | regulation of chromatin binding (GO:0035561) | 2.27983217 |
145 | erythrocyte maturation (GO:0043249) | 2.25335485 |
146 | proline biosynthetic process (GO:0006561) | 2.24928069 |
147 | nucleobase catabolic process (GO:0046113) | 2.23413707 |
148 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.21308553 |
149 | regulation of ARF GTPase activity (GO:0032312) | 2.21070554 |
150 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.20339112 |
151 | clathrin coat assembly (GO:0048268) | 2.18967028 |
152 | histone H3-K9 demethylation (GO:0033169) | 2.18930859 |
153 | sodium ion export (GO:0071436) | 2.18165341 |
154 | cell-cell junction maintenance (GO:0045217) | 2.18000676 |
155 | linoleic acid metabolic process (GO:0043651) | 2.14572617 |
156 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.14526501 |
157 | neurotransmitter secretion (GO:0007269) | 2.13017887 |
158 | cellular response to epinephrine stimulus (GO:0071872) | 2.12037735 |
159 | macroautophagy (GO:0016236) | 2.11978766 |
160 | embryonic process involved in female pregnancy (GO:0060136) | 2.11432296 |
161 | histone H4 deacetylation (GO:0070933) | 2.10594260 |
162 | regulation of cholesterol esterification (GO:0010872) | 2.10360663 |
163 | low-density lipoprotein particle clearance (GO:0034383) | 2.10166617 |
164 | regulation of early endosome to late endosome transport (GO:2000641) | 2.09299760 |
165 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.08673170 |
166 | one-carbon compound transport (GO:0019755) | 2.08659758 |
167 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.08534147 |
168 | regulation of beta-amyloid formation (GO:1902003) | 2.07252246 |
169 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.05050002 |
170 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.04837368 |
171 | actin filament capping (GO:0051693) | 2.04234374 |
172 | establishment of mitochondrion localization (GO:0051654) | 2.02953924 |
173 | proline metabolic process (GO:0006560) | 2.02278650 |
174 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.02155486 |
175 | modulation by virus of host process (GO:0019054) | 2.02134175 |
176 | response to monoamine (GO:0071867) | 2.01929674 |
177 | response to catecholamine (GO:0071869) | 2.01929674 |
178 | amyloid precursor protein catabolic process (GO:0042987) | 2.01419764 |
179 | receptor recycling (GO:0001881) | 2.00318693 |
180 | negative regulation of fatty acid transport (GO:2000192) | 2.00233758 |
181 | cell volume homeostasis (GO:0006884) | 1.98840099 |
182 | activation of MAPKKK activity (GO:0000185) | 1.98680937 |
183 | amyloid precursor protein metabolic process (GO:0042982) | 1.98468385 |
184 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.98031510 |
185 | protein insertion into membrane (GO:0051205) | 1.97337112 |
186 | negative regulation of adherens junction organization (GO:1903392) | 1.96754994 |
187 | negative regulation of cell junction assembly (GO:1901889) | 1.96754994 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.41194443 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04004011 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63802402 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.42266558 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.92242702 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81614330 |
7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.40286404 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37805345 |
9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.34800829 |
10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32603122 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.27321334 |
12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24726349 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.24314955 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16968768 |
15 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.04601111 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02544156 |
17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95290175 |
18 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92400576 |
19 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91221710 |
20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89764403 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86602681 |
22 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.81421734 |
23 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.76474808 |
24 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.74461675 |
25 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73788399 |
26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72676535 |
27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71925664 |
28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63772716 |
29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62609326 |
30 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58743153 |
31 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56277490 |
32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56146361 |
33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55301182 |
34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55101057 |
35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53584782 |
36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52954786 |
37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.52025117 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49879023 |
39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49437281 |
40 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.48147600 |
41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47127868 |
42 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45820823 |
43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.45470106 |
44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44585056 |
45 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42077754 |
46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41160594 |
47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37850956 |
48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36405346 |
49 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.35245087 |
50 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34780762 |
51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34313505 |
52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34164354 |
53 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.33960441 |
54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32630277 |
55 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.31573415 |
56 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29366543 |
57 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29296402 |
58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29118335 |
59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26819469 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25923380 |
61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25748752 |
62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21222254 |
63 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21051364 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20194057 |
65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20105760 |
66 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.18889844 |
67 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.18603095 |
68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16350085 |
69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16056335 |
70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14919861 |
71 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14497880 |
72 | P68_20966046_ChIP-Seq_HELA_Human | 1.14373208 |
73 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13851129 |
74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13319807 |
75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13247953 |
76 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12222037 |
77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12095916 |
78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11228644 |
79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10676158 |
80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09009168 |
81 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08898693 |
82 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08609495 |
83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08335495 |
84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08136787 |
85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06928810 |
86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06752706 |
87 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06329559 |
88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05042542 |
89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04718230 |
90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03545594 |
91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03344339 |
92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02432966 |
93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02306853 |
94 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01625966 |
95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01615812 |
96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01361988 |
97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01094451 |
98 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00514340 |
99 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99003875 |
100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99003875 |
101 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.98548195 |
102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98112387 |
103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97636145 |
104 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97271057 |
105 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96907036 |
106 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96828871 |
107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95504483 |
108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95295965 |
109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95289852 |
110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94950072 |
111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94788953 |
112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94770476 |
113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94036359 |
114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93975732 |
115 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93877711 |
116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93825785 |
117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93631443 |
118 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93135411 |
119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92948918 |
120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92676975 |
121 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91883466 |
122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91315466 |
123 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90825439 |
124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89650060 |
125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87474667 |
126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.86828386 |
127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86820922 |
128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86628443 |
129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85646531 |
130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85527148 |
131 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85407597 |
132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85336208 |
133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84903241 |
134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84287494 |
135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83929177 |
136 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.83213333 |
137 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.83213333 |
138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82892470 |
139 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81802918 |
140 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81055516 |
141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79951293 |
142 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79814170 |
143 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79076166 |
144 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78989567 |
145 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78663053 |
146 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78579144 |
147 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.78579144 |
148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78089507 |
149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78005471 |
150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77825677 |
151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77653081 |
152 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77522360 |
153 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.77139945 |
154 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.76166439 |
155 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75732366 |
156 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.75274639 |
157 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75040360 |
158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75007436 |
159 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.74930098 |
160 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73862701 |
161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73670860 |
162 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72942701 |
163 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72923389 |
164 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.72650552 |
165 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72277418 |
166 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.71575900 |
167 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70956791 |
168 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70731527 |
169 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70538952 |
170 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.70249387 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.54152953 |
2 | MP0005360_urolithiasis | 5.05921457 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.18006690 |
4 | MP0005365_abnormal_bile_salt | 3.95100266 |
5 | MP0003656_abnormal_erythrocyte_physiolo | 3.80920650 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.67446237 |
7 | MP0004859_abnormal_synaptic_plasticity | 3.30140886 |
8 | MP0005083_abnormal_biliary_tract | 3.14819803 |
9 | MP0003806_abnormal_nucleotide_metabolis | 2.85123894 |
10 | MP0004147_increased_porphyrin_level | 2.66149440 |
11 | MP0003195_calcinosis | 2.51862519 |
12 | MP0003252_abnormal_bile_duct | 2.47959746 |
13 | MP0009840_abnormal_foam_cell | 2.42936849 |
14 | MP0000920_abnormal_myelination | 2.36543833 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.36055916 |
16 | MP0010329_abnormal_lipoprotein_level | 2.34146583 |
17 | MP0005332_abnormal_amino_acid | 2.25316456 |
18 | MP0003690_abnormal_glial_cell | 2.22462967 |
19 | MP0001666_abnormal_nutrient_absorption | 2.18662299 |
20 | MP0003879_abnormal_hair_cell | 2.05732784 |
21 | MP0005464_abnormal_platelet_physiology | 2.01890220 |
22 | MP0003705_abnormal_hypodermis_morpholog | 2.00789445 |
23 | MP0005409_darkened_coat_color | 1.99880022 |
24 | MP0002118_abnormal_lipid_homeostasis | 1.99453530 |
25 | MP0003172_abnormal_lysosome_physiology | 1.98922061 |
26 | MP0008438_abnormal_cutaneous_collagen | 1.95617005 |
27 | MP0003329_amyloid_beta_deposits | 1.94462576 |
28 | MP0002837_dystrophic_cardiac_calcinosis | 1.87240268 |
29 | MP0005451_abnormal_body_composition | 1.85993769 |
30 | MP0008995_early_reproductive_senescence | 1.85774347 |
31 | MP0003303_peritoneal_inflammation | 1.80602305 |
32 | MP0005423_abnormal_somatic_nervous | 1.69874667 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.67070931 |
34 | MP0003880_abnormal_central_pattern | 1.66555937 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.66294050 |
36 | MP0000609_abnormal_liver_physiology | 1.57544377 |
37 | MP0000604_amyloidosis | 1.57241676 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.52511382 |
39 | MP0001545_abnormal_hematopoietic_system | 1.52511382 |
40 | MP0003566_abnormal_cell_adhesion | 1.51237900 |
41 | MP0002653_abnormal_ependyma_morphology | 1.50993030 |
42 | MP0003436_decreased_susceptibility_to | 1.48719544 |
43 | MP0004043_abnormal_pH_regulation | 1.46125742 |
44 | MP0009278_abnormal_bone_marrow | 1.43349378 |
45 | MP0009643_abnormal_urine_homeostasis | 1.41703997 |
46 | MP0004019_abnormal_vitamin_homeostasis | 1.41355106 |
47 | MP0008569_lethality_at_weaning | 1.39481280 |
48 | MP0002254_reproductive_system_inflammat | 1.39242680 |
49 | MP0004185_abnormal_adipocyte_glucose | 1.38145828 |
50 | MP0005636_abnormal_mineral_homeostasis | 1.36437738 |
51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35228974 |
52 | MP0004130_abnormal_muscle_cell | 1.35056809 |
53 | MP0002063_abnormal_learning/memory/cond | 1.34441798 |
54 | MP0009384_cardiac_valve_regurgitation | 1.31627478 |
55 | MP0004270_analgesia | 1.30918825 |
56 | MP0004811_abnormal_neuron_physiology | 1.24342796 |
57 | MP0001502_abnormal_circadian_rhythm | 1.22529451 |
58 | MP0002796_impaired_skin_barrier | 1.21402846 |
59 | MP0003868_abnormal_feces_composition | 1.19482663 |
60 | MP0001958_emphysema | 1.18309264 |
61 | MP0005167_abnormal_blood-brain_barrier | 1.17743998 |
62 | MP0001765_abnormal_ion_homeostasis | 1.15676186 |
63 | MP0003828_pulmonary_edema | 1.14962102 |
64 | MP0003279_aneurysm | 1.14429869 |
65 | MP0008004_abnormal_stomach_pH | 1.13891033 |
66 | MP0003091_abnormal_cell_migration | 1.11913459 |
67 | MP0003122_maternal_imprinting | 1.11455258 |
68 | MP0004885_abnormal_endolymph | 1.08900192 |
69 | MP0005319_abnormal_enzyme/_coenzyme | 1.07934057 |
70 | MP0002089_abnormal_postnatal_growth/wei | 1.06037132 |
71 | MP0002971_abnormal_brown_adipose | 1.05670580 |
72 | MP0004510_myositis | 1.05075731 |
73 | MP0005058_abnormal_lysosome_morphology | 1.03540710 |
74 | MP0006138_congestive_heart_failure | 1.01674776 |
75 | MP0009765_abnormal_xenobiotic_induced | 1.01107506 |
76 | MP0001529_abnormal_vocalization | 1.01075873 |
77 | MP0005275_abnormal_skin_tensile | 1.00353389 |
78 | MP0005535_abnormal_body_temperature | 0.99640282 |
79 | MP0005076_abnormal_cell_differentiation | 0.98712156 |
80 | MP0002909_abnormal_adrenal_gland | 0.98517338 |
81 | MP0010678_abnormal_skin_adnexa | 0.98225114 |
82 | MP0001661_extended_life_span | 0.97891401 |
83 | MP0005666_abnormal_adipose_tissue | 0.97775511 |
84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95350770 |
85 | MP0003634_abnormal_glial_cell | 0.92978143 |
86 | MP0002249_abnormal_larynx_morphology | 0.91888791 |
87 | MP0003950_abnormal_plasma_membrane | 0.91721060 |
88 | MP0000681_abnormal_thyroid_gland | 0.91045144 |
89 | MP0004947_skin_inflammation | 0.90629785 |
90 | MP0001915_intracranial_hemorrhage | 0.89740980 |
91 | MP0005375_adipose_tissue_phenotype | 0.84827570 |
92 | MP0000678_abnormal_parathyroid_gland | 0.84689421 |
93 | MP0002734_abnormal_mechanical_nocicepti | 0.84460334 |
94 | MP0000778_abnormal_nervous_system | 0.84385559 |
95 | MP0004036_abnormal_muscle_relaxation | 0.83065757 |
96 | MP0000747_muscle_weakness | 0.82066383 |
97 | MP0005647_abnormal_sex_gland | 0.81437257 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.80676953 |
99 | MP0001756_abnormal_urination | 0.80416093 |
100 | MP0002078_abnormal_glucose_homeostasis | 0.79281011 |
101 | MP0002735_abnormal_chemical_nociception | 0.78824016 |
102 | MP0002822_catalepsy | 0.78459499 |
103 | MP0005670_abnormal_white_adipose | 0.77438841 |
104 | MP0002882_abnormal_neuron_morphology | 0.77108620 |
105 | MP0004742_abnormal_vestibular_system | 0.76835494 |
106 | MP0005410_abnormal_fertilization | 0.75715826 |
107 | MP0002064_seizures | 0.75620088 |
108 | MP0001440_abnormal_grooming_behavior | 0.74755665 |
109 | MP0005171_absent_coat_pigmentation | 0.74546774 |
110 | MP0000465_gastrointestinal_hemorrhage | 0.74175964 |
111 | MP0004142_abnormal_muscle_tone | 0.73909098 |
112 | MP0008874_decreased_physiological_sensi | 0.73876496 |
113 | MP0002229_neurodegeneration | 0.73770137 |
114 | MP0000003_abnormal_adipose_tissue | 0.73179755 |
115 | MP0000230_abnormal_systemic_arterial | 0.73151971 |
116 | MP0006276_abnormal_autonomic_nervous | 0.73079711 |
117 | MP0001849_ear_inflammation | 0.72792092 |
118 | MP0009764_decreased_sensitivity_to | 0.72516863 |
119 | MP0002733_abnormal_thermal_nociception | 0.72444524 |
120 | MP0001764_abnormal_homeostasis | 0.72433635 |
121 | MP0008775_abnormal_heart_ventricle | 0.72368550 |
122 | MP0004883_abnormal_blood_vessel | 0.72343338 |
123 | MP0005334_abnormal_fat_pad | 0.72171626 |
124 | MP0003075_altered_response_to | 0.72062552 |
125 | MP0003632_abnormal_nervous_system | 0.71669225 |
126 | MP0001486_abnormal_startle_reflex | 0.70717591 |
127 | MP0001970_abnormal_pain_threshold | 0.70066041 |
128 | MP0005310_abnormal_salivary_gland | 0.69813064 |
129 | MP0000955_abnormal_spinal_cord | 0.69784962 |
130 | MP0002066_abnormal_motor_capabilities/c | 0.69022079 |
131 | MP0003948_abnormal_gas_homeostasis | 0.68729425 |
132 | MP0002876_abnormal_thyroid_physiology | 0.68484699 |
133 | MP0005408_hypopigmentation | 0.67786978 |
134 | MP0000383_abnormal_hair_follicle | 0.65871488 |
135 | MP0002132_abnormal_respiratory_system | 0.65468787 |
136 | MP0000249_abnormal_blood_vessel | 0.65212284 |
137 | MP0002572_abnormal_emotion/affect_behav | 0.64534029 |
138 | MP0003633_abnormal_nervous_system | 0.64425978 |
139 | MP0002136_abnormal_kidney_physiology | 0.63988586 |
140 | MP0001533_abnormal_skeleton_physiology | 0.63980805 |
141 | MP0002557_abnormal_social/conspecific_i | 0.62587925 |
142 | MP0009763_increased_sensitivity_to | 0.62284661 |
143 | MP0001851_eye_inflammation | 0.61865860 |
144 | MP0003631_nervous_system_phenotype | 0.61434237 |
145 | MP0002332_abnormal_exercise_endurance | 0.60677443 |
146 | MP0002295_abnormal_pulmonary_circulatio | 0.59993845 |
147 | MP0009642_abnormal_blood_homeostasis | 0.59844193 |
148 | MP0003186_abnormal_redox_activity | 0.59702883 |
149 | MP0001346_abnormal_lacrimal_gland | 0.59266604 |
150 | MP0002090_abnormal_vision | 0.58416350 |
151 | MP0008260_abnormal_autophagy | 0.57261787 |
152 | MP0005501_abnormal_skin_physiology | 0.56543268 |
153 | MP0006036_abnormal_mitochondrial_physio | 0.55641903 |
154 | MP0003724_increased_susceptibility_to | 0.54759746 |
155 | MP0005376_homeostasis/metabolism_phenot | 0.54325409 |
156 | MP0000598_abnormal_liver_morphology | 0.51620452 |
157 | MP0005164_abnormal_response_to | 0.50074240 |
158 | MP0003300_gastrointestinal_ulcer | 0.49777804 |
159 | MP0006082_CNS_inflammation | 0.49463558 |
160 | MP0008469_abnormal_protein_level | 0.49376573 |
161 | MP0005620_abnormal_muscle_contractility | 0.49233977 |
162 | MP0000462_abnormal_digestive_system | 0.48857262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 5.28173629 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.65779700 |
3 | Deep venous thrombosis (HP:0002625) | 4.61869841 |
4 | Xanthomatosis (HP:0000991) | 4.23398643 |
5 | Poikilocytosis (HP:0004447) | 4.17146148 |
6 | Acanthocytosis (HP:0001927) | 4.07334365 |
7 | Neurofibrillary tangles (HP:0002185) | 3.97502097 |
8 | Hyperlipoproteinemia (HP:0010980) | 3.83212521 |
9 | Hypobetalipoproteinemia (HP:0003563) | 3.50014881 |
10 | Abnormal gallbladder morphology (HP:0012437) | 3.48074254 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.47471452 |
12 | Cholelithiasis (HP:0001081) | 3.45147543 |
13 | Ketosis (HP:0001946) | 3.44299579 |
14 | Hypochromic microcytic anemia (HP:0004840) | 3.34649786 |
15 | Prolonged partial thromboplastin time (HP:0003645) | 3.30744534 |
16 | Cerebral inclusion bodies (HP:0100314) | 3.26957628 |
17 | Complement deficiency (HP:0004431) | 3.12172719 |
18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.01790305 |
19 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.01790305 |
20 | Prolonged bleeding time (HP:0003010) | 2.99614496 |
21 | Hypolipoproteinemia (HP:0010981) | 2.88139264 |
22 | Hyperammonemia (HP:0001987) | 2.86914525 |
23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.84755219 |
24 | Ankle clonus (HP:0011448) | 2.82733933 |
25 | Ketoacidosis (HP:0001993) | 2.82731157 |
26 | Abnormality of glycine metabolism (HP:0010895) | 2.82248268 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.82248268 |
28 | Hyporeflexia of lower limbs (HP:0002600) | 2.82075390 |
29 | Cholecystitis (HP:0001082) | 2.82037132 |
30 | Abnormal gallbladder physiology (HP:0012438) | 2.82037132 |
31 | Hyperbilirubinemia (HP:0002904) | 2.81466073 |
32 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79830055 |
33 | Obstructive sleep apnea (HP:0002870) | 2.79398766 |
34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79027131 |
35 | Menorrhagia (HP:0000132) | 2.78358923 |
36 | Cerebral hemorrhage (HP:0001342) | 2.78119210 |
37 | Reticulocytosis (HP:0001923) | 2.76311105 |
38 | Hypoglycemic coma (HP:0001325) | 2.76204157 |
39 | Hypoalphalipoproteinemia (HP:0003233) | 2.71867611 |
40 | Parakeratosis (HP:0001036) | 2.68680242 |
41 | Fat malabsorption (HP:0002630) | 2.67180857 |
42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.65510699 |
43 | Hand muscle atrophy (HP:0009130) | 2.64488019 |
44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.58048066 |
45 | Hyperglycinemia (HP:0002154) | 2.57828670 |
46 | Upper limb amyotrophy (HP:0009129) | 2.56631348 |
47 | Distal upper limb amyotrophy (HP:0007149) | 2.56631348 |
48 | Gout (HP:0001997) | 2.54960946 |
49 | Hyperglycinuria (HP:0003108) | 2.54949594 |
50 | Epidermoid cyst (HP:0200040) | 2.54571824 |
51 | Abnormality of the corticospinal tract (HP:0002492) | 2.53672416 |
52 | Abnormality of the gallbladder (HP:0005264) | 2.50493110 |
53 | Hemorrhage of the eye (HP:0011885) | 2.50265045 |
54 | Mitral stenosis (HP:0001718) | 2.48337022 |
55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.47871772 |
56 | Growth hormone excess (HP:0000845) | 2.46404535 |
57 | Hammertoe (HP:0001765) | 2.44578501 |
58 | Rickets (HP:0002748) | 2.43984049 |
59 | Abnormality of reticulocytes (HP:0004312) | 2.42163748 |
60 | Paralysis (HP:0003470) | 2.41756918 |
61 | Amyloidosis (HP:0011034) | 2.37806604 |
62 | Polycythemia (HP:0001901) | 2.37730570 |
63 | Onion bulb formation (HP:0003383) | 2.36336990 |
64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34527950 |
65 | Global brain atrophy (HP:0002283) | 2.32367418 |
66 | Distal lower limb amyotrophy (HP:0008944) | 2.28225910 |
67 | Protrusio acetabuli (HP:0003179) | 2.26993234 |
68 | Abnormal hemoglobin (HP:0011902) | 2.25772532 |
69 | Metabolic acidosis (HP:0001942) | 2.25397628 |
70 | Cerebral aneurysm (HP:0004944) | 2.24736932 |
71 | Vascular calcification (HP:0004934) | 2.22829173 |
72 | Joint hemorrhage (HP:0005261) | 2.20163391 |
73 | Confusion (HP:0001289) | 2.19369495 |
74 | Purpura (HP:0000979) | 2.18475456 |
75 | Abnormality of purine metabolism (HP:0004352) | 2.17207027 |
76 | Increased mean platelet volume (HP:0011877) | 2.16894907 |
77 | Abnormality of methionine metabolism (HP:0010901) | 2.16244220 |
78 | Hypophosphatemic rickets (HP:0004912) | 2.15364617 |
79 | Hypercortisolism (HP:0001578) | 2.14969001 |
80 | Gingival bleeding (HP:0000225) | 2.13572622 |
81 | Epistaxis (HP:0000421) | 2.13232692 |
82 | Spastic gait (HP:0002064) | 2.13162606 |
83 | Atelectasis (HP:0100750) | 2.12106655 |
84 | Exercise-induced myalgia (HP:0003738) | 2.10706378 |
85 | Diaphragmatic weakness (HP:0009113) | 2.10531661 |
86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10191533 |
87 | Spastic paraparesis (HP:0002313) | 2.09920037 |
88 | Intention tremor (HP:0002080) | 2.09340205 |
89 | Decreased motor nerve conduction velocity (HP:0003431) | 2.07382910 |
90 | Neoplasm of the heart (HP:0100544) | 2.07234669 |
91 | Increased circulating renin level (HP:0000848) | 2.06859076 |
92 | Hypoglycemic seizures (HP:0002173) | 2.05529695 |
93 | Steatorrhea (HP:0002570) | 2.04640471 |
94 | Muscle fiber splitting (HP:0003555) | 2.04281238 |
95 | Neuronal loss in central nervous system (HP:0002529) | 2.04167095 |
96 | Abnormal platelet volume (HP:0011876) | 2.03410524 |
97 | Insomnia (HP:0100785) | 2.02092233 |
98 | Hypercholesterolemia (HP:0003124) | 2.01936386 |
99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00949377 |
100 | Upper limb muscle weakness (HP:0003484) | 1.99728578 |
101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99014229 |
102 | Axonal loss (HP:0003447) | 1.97768525 |
103 | Abnormality of binocular vision (HP:0011514) | 1.95598209 |
104 | Diplopia (HP:0000651) | 1.95598209 |
105 | Polyphagia (HP:0002591) | 1.94593804 |
106 | Myocardial infarction (HP:0001658) | 1.94236989 |
107 | Bowel incontinence (HP:0002607) | 1.93874600 |
108 | Hypokalemic alkalosis (HP:0001949) | 1.93699399 |
109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93528321 |
110 | Cardiovascular calcification (HP:0011915) | 1.91485475 |
111 | Abnormality of complement system (HP:0005339) | 1.91109082 |
112 | Abnormal large intestine physiology (HP:0012700) | 1.89342560 |
113 | Lower limb amyotrophy (HP:0007210) | 1.89083747 |
114 | Peripheral hypomyelination (HP:0007182) | 1.89062045 |
115 | Supranuclear gaze palsy (HP:0000605) | 1.89027695 |
116 | Easy fatigability (HP:0003388) | 1.87748881 |
117 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.87714861 |
118 | Postural instability (HP:0002172) | 1.86406379 |
119 | Spastic tetraparesis (HP:0001285) | 1.85925489 |
120 | Difficulty climbing stairs (HP:0003551) | 1.85759590 |
121 | Peripheral demyelination (HP:0011096) | 1.85676328 |
122 | Eczematoid dermatitis (HP:0000976) | 1.85664224 |
123 | Truncus arteriosus (HP:0001660) | 1.85585653 |
124 | Interstitial pulmonary disease (HP:0006530) | 1.85274876 |
125 | Spontaneous abortion (HP:0005268) | 1.84426083 |
126 | Distal sensory impairment (HP:0002936) | 1.84321493 |
127 | Arterial tortuosity (HP:0005116) | 1.84282831 |
128 | Ileus (HP:0002595) | 1.84111875 |
129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83669770 |
130 | Alkalosis (HP:0001948) | 1.82816346 |
131 | Systemic lupus erythematosus (HP:0002725) | 1.82608690 |
132 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.82399876 |
133 | Abnormality of proline metabolism (HP:0010907) | 1.81820917 |
134 | Hydroxyprolinuria (HP:0003080) | 1.81820917 |
135 | Paraparesis (HP:0002385) | 1.81514184 |
136 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.81350622 |
137 | Hypoplasia of the iris (HP:0007676) | 1.80124078 |
138 | Aneurysm (HP:0002617) | 1.79865217 |
139 | Sleep apnea (HP:0010535) | 1.79419246 |
140 | Insidious onset (HP:0003587) | 1.79271539 |
141 | Termporal pattern (HP:0011008) | 1.79271539 |
142 | Increased purine levels (HP:0004368) | 1.79004817 |
143 | Hyperuricemia (HP:0002149) | 1.79004817 |
144 | Foot dorsiflexor weakness (HP:0009027) | 1.78779064 |
145 | Testicular neoplasm (HP:0010788) | 1.78099459 |
146 | Abnormality of the fingertips (HP:0001211) | 1.77492929 |
147 | Disproportionate tall stature (HP:0001519) | 1.77332260 |
148 | Germ cell neoplasia (HP:0100728) | 1.77245053 |
149 | Abnormality of the intrinsic pathway (HP:0010989) | 1.76869837 |
150 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76862693 |
151 | Abnormal platelet function (HP:0011869) | 1.76860293 |
152 | Impaired platelet aggregation (HP:0003540) | 1.76860293 |
153 | Dysostosis multiplex (HP:0000943) | 1.76323248 |
154 | Microcytic anemia (HP:0001935) | 1.75080452 |
155 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74241996 |
156 | Abnormality of the Achilles tendon (HP:0005109) | 1.73987649 |
157 | Sensorimotor neuropathy (HP:0007141) | 1.73555366 |
158 | Sensory axonal neuropathy (HP:0003390) | 1.73113695 |
159 | Hepatocellular carcinoma (HP:0001402) | 1.72826088 |
160 | Hypoventilation (HP:0002791) | 1.72012989 |
161 | Metabolic alkalosis (HP:0200114) | 1.71872021 |
162 | Slow saccadic eye movements (HP:0000514) | 1.71483796 |
163 | Protuberant abdomen (HP:0001538) | 1.71351784 |
164 | Cervical subluxation (HP:0003308) | 1.70793551 |
165 | Abnormal eating behavior (HP:0100738) | 1.70755980 |
166 | Broad palm (HP:0001169) | 1.69754308 |
167 | Myokymia (HP:0002411) | 1.69117112 |
168 | Vascular tortuosity (HP:0004948) | 1.68636302 |
169 | Skin nodule (HP:0200036) | 1.67524515 |
170 | Aortic aneurysm (HP:0004942) | 1.66933146 |
171 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.66013743 |
172 | Depression (HP:0000716) | 1.65155323 |
173 | Lower limb muscle weakness (HP:0007340) | 1.65093614 |
174 | Hypertriglyceridemia (HP:0002155) | 1.61562594 |
175 | Metaphyseal cupping (HP:0003021) | 1.61135508 |
176 | Dysmetric saccades (HP:0000641) | 1.59165161 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.86862233 |
2 | EPHB1 | 3.74768940 |
3 | WNK4 | 3.42828750 |
4 | OXSR1 | 3.17952582 |
5 | PRPF4B | 2.85906750 |
6 | MARK1 | 2.20640149 |
7 | BCKDK | 2.19728714 |
8 | RIPK1 | 2.03181812 |
9 | ICK | 1.99024971 |
10 | WNK1 | 1.92721940 |
11 | PKN1 | 1.91772358 |
12 | CAMK1G | 1.87966276 |
13 | MAPK15 | 1.83717950 |
14 | FGFR2 | 1.70409790 |
15 | TAOK3 | 1.69547905 |
16 | ERN1 | 1.68664836 |
17 | INSRR | 1.64557842 |
18 | FGFR4 | 1.59233911 |
19 | SIK1 | 1.55948707 |
20 | MST4 | 1.55288695 |
21 | KSR1 | 1.53816060 |
22 | SIK2 | 1.52973279 |
23 | NTRK3 | 1.47102858 |
24 | MET | 1.46695930 |
25 | MAP3K6 | 1.44093559 |
26 | PNCK | 1.41059938 |
27 | PAK3 | 1.39485267 |
28 | SIK3 | 1.37888184 |
29 | EEF2K | 1.36645109 |
30 | CAMK1D | 1.36188460 |
31 | NTRK1 | 1.35456287 |
32 | PKN2 | 1.26803519 |
33 | MAP3K3 | 1.25917674 |
34 | MAPKAPK5 | 1.25066856 |
35 | CDK12 | 1.23452477 |
36 | PRKD3 | 1.18197212 |
37 | EPHA4 | 1.16263217 |
38 | MAP2K3 | 1.12726506 |
39 | PRKAA2 | 1.10781238 |
40 | PDGFRA | 1.08084715 |
41 | PRKCQ | 1.07885283 |
42 | STK38 | 1.06797690 |
43 | TAOK1 | 1.05239945 |
44 | MAP3K11 | 1.03011033 |
45 | DDR2 | 1.01675277 |
46 | PDPK1 | 1.01214810 |
47 | DMPK | 1.01021291 |
48 | SGK494 | 1.00929840 |
49 | SGK223 | 1.00929840 |
50 | EPHA3 | 1.00801287 |
51 | FGR | 0.99075177 |
52 | MAP3K4 | 0.98273672 |
53 | PRKD2 | 0.97186202 |
54 | ERBB4 | 0.97160672 |
55 | FGFR3 | 0.95122156 |
56 | MAP3K2 | 0.94787338 |
57 | MARK2 | 0.94271418 |
58 | GSK3A | 0.94199603 |
59 | MAP2K7 | 0.93455589 |
60 | TAOK2 | 0.93252985 |
61 | MELK | 0.92796586 |
62 | BCR | 0.91690629 |
63 | PAK6 | 0.91107290 |
64 | CSNK1A1L | 0.90137872 |
65 | CDK19 | 0.89327433 |
66 | CLK1 | 0.88509471 |
67 | ITK | 0.86531832 |
68 | CSNK1G3 | 0.85056478 |
69 | RAF1 | 0.83685742 |
70 | DYRK1A | 0.83060814 |
71 | TESK1 | 0.82690573 |
72 | RPS6KA2 | 0.81958193 |
73 | MAPK12 | 0.81524171 |
74 | ROCK2 | 0.80655939 |
75 | CDC42BPA | 0.80321185 |
76 | JAK2 | 0.80230979 |
77 | NTRK2 | 0.78903974 |
78 | SGK3 | 0.78726286 |
79 | IRAK2 | 0.77786501 |
80 | CSNK1G2 | 0.76669882 |
81 | PRKD1 | 0.76625554 |
82 | PRKAA1 | 0.76010290 |
83 | TBK1 | 0.75980197 |
84 | JAK1 | 0.75707252 |
85 | ZAP70 | 0.74128519 |
86 | PTK2 | 0.73247686 |
87 | STK11 | 0.72682185 |
88 | IRAK3 | 0.72640747 |
89 | TYRO3 | 0.72044964 |
90 | PTK6 | 0.71390488 |
91 | CAMK2B | 0.70701157 |
92 | CAMK2G | 0.69875812 |
93 | DYRK2 | 0.68352916 |
94 | DYRK1B | 0.68347062 |
95 | CSNK1G1 | 0.67990041 |
96 | BMPR2 | 0.67248303 |
97 | MINK1 | 0.67071527 |
98 | PHKG1 | 0.67037495 |
99 | PHKG2 | 0.67037495 |
100 | MTOR | 0.66313718 |
101 | FER | 0.66220128 |
102 | MAP3K5 | 0.66085980 |
103 | DAPK2 | 0.65535130 |
104 | MAP3K7 | 0.64985470 |
105 | LMTK2 | 0.63441565 |
106 | TRPM7 | 0.62519474 |
107 | DYRK3 | 0.62506020 |
108 | PTK2B | 0.62051689 |
109 | MAP2K2 | 0.61643945 |
110 | MAP3K1 | 0.61571589 |
111 | PDK1 | 0.61505467 |
112 | IRAK1 | 0.61472632 |
113 | HIPK2 | 0.61289617 |
114 | MAP2K4 | 0.60792576 |
115 | CAMK2D | 0.60717394 |
116 | CAMKK1 | 0.60393867 |
117 | TRIB3 | 0.60148953 |
118 | PDGFRB | 0.58605159 |
119 | CSK | 0.57984220 |
120 | GRK7 | 0.57910775 |
121 | ERBB2 | 0.57719098 |
122 | MAPK11 | 0.56668989 |
123 | WNK3 | 0.56538699 |
124 | RIPK4 | 0.56454277 |
125 | AKT3 | 0.55975604 |
126 | SGK2 | 0.55871140 |
127 | MST1R | 0.54882544 |
128 | PIM2 | 0.54673218 |
129 | UHMK1 | 0.54151970 |
130 | STK10 | 0.53386066 |
131 | CAMK2A | 0.53006908 |
132 | PRKCH | 0.51308447 |
133 | CDK5 | 0.51011907 |
134 | KSR2 | 0.50976328 |
135 | GRK6 | 0.50918788 |
136 | TYK2 | 0.50477759 |
137 | EIF2AK1 | 0.49794680 |
138 | TIE1 | 0.48369339 |
139 | MAPK4 | 0.48274930 |
140 | GRK5 | 0.48178896 |
141 | TNK2 | 0.47780139 |
142 | MAPK10 | 0.47678652 |
143 | PRKACG | 0.47657506 |
144 | RPS6KA5 | 0.47538452 |
145 | RET | 0.46970014 |
146 | MAP2K1 | 0.46660233 |
147 | PIK3CG | 0.46432707 |
148 | NEK6 | 0.46021792 |
149 | PRKCZ | 0.45952012 |
150 | SGK1 | 0.45665730 |
151 | LATS1 | 0.44043381 |
152 | BMX | 0.43516871 |
153 | FYN | 0.42916473 |
154 | MAPK7 | 0.41595988 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21135859 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.99651774 |
3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64233201 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50877469 |
5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42298811 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40736757 |
7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.31301990 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.26761544 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.24824175 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.17448903 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16213898 |
12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.15280123 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14687892 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12832482 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12106415 |
16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99239565 |
17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.96865404 |
18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92670774 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92188188 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91662404 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81116229 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76414998 |
23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.72474691 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71512102 |
25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.70281121 |
26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67933303 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.66168484 |
28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60975625 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53260715 |
30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50052110 |
31 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47156914 |
32 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43387551 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.37348421 |
34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.37164073 |
35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36488690 |
36 | ABC transporters_Homo sapiens_hsa02010 | 1.35352187 |
37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34926632 |
38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34551101 |
39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31844436 |
40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30987737 |
41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29189538 |
42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28735495 |
43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27672845 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23537517 |
45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23414170 |
46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22180224 |
47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22177165 |
48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20110515 |
49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.19767786 |
50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.19553454 |
51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19405552 |
52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15878155 |
53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15629826 |
54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14852668 |
55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14837875 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14317744 |
57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13456642 |
58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10543949 |
59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09924473 |
60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06906886 |
61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06336203 |
62 | Gap junction_Homo sapiens_hsa04540 | 1.06277394 |
63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05546013 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04998634 |
65 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04372273 |
66 | Long-term potentiation_Homo sapiens_hsa04720 | 1.01220370 |
67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99429190 |
68 | Glioma_Homo sapiens_hsa05214 | 0.99285553 |
69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99210442 |
70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97223944 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96713444 |
72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96078798 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95979080 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95549421 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91589070 |
76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90377104 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.90361105 |
78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.90251839 |
79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85602198 |
80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83894669 |
81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82946131 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81862369 |
83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81089431 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80410321 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79797345 |
86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78541469 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.78528231 |
88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78508242 |
89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77336172 |
90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74900777 |
91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74532948 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73928126 |
93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73577457 |
94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73039016 |
95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.70976194 |
96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70450413 |
97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69957158 |
98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69620569 |
99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68980230 |
100 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68145351 |
101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67832705 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67036003 |
103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66589546 |
104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66481886 |
105 | Hepatitis C_Homo sapiens_hsa05160 | 0.65137911 |
106 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65102809 |
107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64919706 |
108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64255674 |
109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63701478 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63011173 |
111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62553388 |
112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62493497 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.61323258 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60250422 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59598141 |
116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58485477 |
117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58062112 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57785606 |
119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.56845867 |
120 | Morphine addiction_Homo sapiens_hsa05032 | 0.56819065 |
121 | Hepatitis B_Homo sapiens_hsa05161 | 0.55784154 |
122 | Focal adhesion_Homo sapiens_hsa04510 | 0.54606531 |
123 | Amoebiasis_Homo sapiens_hsa05146 | 0.54483312 |
124 | Prostate cancer_Homo sapiens_hsa05215 | 0.54200332 |
125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53345126 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53124171 |
127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51783540 |
128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.50511793 |
129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48592560 |
130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48269224 |
131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.48208569 |
132 | Insulin resistance_Homo sapiens_hsa04931 | 0.43320478 |
133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42671734 |
134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41194717 |
135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39482647 |
136 | Prion diseases_Homo sapiens_hsa05020 | 0.35974040 |
137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34986272 |
138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33109954 |
139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32431490 |
140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31213487 |
141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30978032 |
142 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30568443 |
143 | GABAergic synapse_Homo sapiens_hsa04727 | 0.29164213 |
144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28804625 |
145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28453727 |
146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28062818 |
147 | Mineral absorption_Homo sapiens_hsa04978 | 0.26408432 |
148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25836392 |
149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22825917 |
150 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22020391 |
151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21890528 |
152 | Lysosome_Homo sapiens_hsa04142 | 0.21743547 |
153 | Axon guidance_Homo sapiens_hsa04360 | 0.21080010 |
154 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20541958 |
155 | Renin secretion_Homo sapiens_hsa04924 | 0.19500689 |
156 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18633417 |
157 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17228794 |
158 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17002405 |
159 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.16682923 |
160 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11774115 |
161 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11755999 |
162 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11553958 |
163 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.11426060 |
164 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11085097 |
165 | Endocytosis_Homo sapiens_hsa04144 | 0.10950394 |
166 | Tight junction_Homo sapiens_hsa04530 | 0.09515844 |
167 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08995271 |